Stocks to Watch: Stocks to watch: Oracle, Smith & Wesson, Family Dollar

Stock Market

SAN FRANCISCO (MarketWatch) — Among the companies whose shares are expected to see active trade in Friday’s session are Oracle Corp., Smith & Wesson Holding Corp., and Family Dollar Stores Inc.

After Thursday’s closing bell, Oracle
ORCL,
-0.80%

 said its fiscal fourth-quarter profit fell to $3.65 billion from $3.81 billion a year earlier. Per-share earnings were unchanged at 80 cents a share while adjusted earnings came in at 92 cents a share, short of 95 cents a share forecast by analysts in a FactSet survey. Revenue rose $11.3 billion from $10.95 billion. Oracle shares declined more than 6% in after-hours trading.

Oracle Corp. signage is displayed outside of the company’s headquarters in Redwood City, Calif.


Bloomberg

Smith & Wesson
US:SWHC
 reported fiscal fourth-quarter profit of $25.1 million, or 45 cents a share, compared with $25.2 million, or 39 cents a share, a year ago. Revenue fell to $170.4 million from $178.7 million. In the current quarter, the company expects to earn between 23 cents and 25 cents a share and between $1.30 and $1.40 a share for the full year. Analysts are projecting earnings of $1.50 a share for the full year. Shares of Smith & Wesson dropped 12% in after hours.

Activist investor Carl Icahn released a letter to Family Dollar Stores’ Chief Executive Howard Levine in which he noted their differences over the future of the company. Icahn, who holds a 9.4% stake in the discount retailer chain, believes the company can do more to be competitive and warned that “consolidation in this space is inevitable.” Shares of Family Dollar
US:FDO
 rose 2.7% in after hours.

More must-reads from MarketWatch:

Oil’s surge might ‘tip the scale toward a correction’ – video chat highlights

10 founders booted out of their own companies

Stocks’ rise to records fails to lift Wall Street forecasts

Articles You May Like

Nike shares jump after sportswear maker replaces chief executive
Guam airport authority bringing $62M Baa2-rated deal
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
NAFOA changes leadership, plans push on bond bill
Muni YTD returns highest since October 2023